Figure S1. CDK4 inhibition by palbociclib treatment inhibits RB1 phosphorylation. MCL cell lines Jeko-1 and Granta-519 were treated with 300 nM and MCL cell line Mino with 100 nM palbociclib. After 16 h, proteins were analyzed by Western blot. (TIFF 360 kb
Figure S13. NOXA protein contains a potential LIR motif. The amino acid sequence DGFRRL at the posit...
Figure S1. Confirmation of silencing of BMX, NRTK2, and PDPK1 mediated by siRNA (set 1- #1) knockdow...
Figure S1. Original blots of Western blot. Original blots of Fig. 1. (2) Original blots of Fig. 2. (...
Figure S7. Palbociclib treatment induces autophagy but not after a short treatment period. (A) MCL c...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S6. Palbociclib-mediated antagonism on bortezomib-induced cell death is not caused by alterat...
Figure S5. Inhibition CDK4 activity hardly alters NOXA mRNA levels after proteasome inhibition. MCL ...
Figure S4. CDK4 inhibition antagonizes cell death of NOXA inducing substances. MCL cell line Jeko-1 ...
Figure S2. Knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death. MCL cell line ...
Figure S11. Combination of proteasome inhibition and simultaneous fatty acid inhibition regulates ma...
Figure S3. Double knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death similar ...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...
Table S1. Sequences targeted by the siRNAs used for gene silencing. (TIFF 883 kb
Figure S10. Synergistic cell death after proteasome inhibition and simultaneous fatty acid inhibitio...
Figure S12. Proteasome inhibitors combined with fatty acid inhibition induce synergistic cell death....
Figure S13. NOXA protein contains a potential LIR motif. The amino acid sequence DGFRRL at the posit...
Figure S1. Confirmation of silencing of BMX, NRTK2, and PDPK1 mediated by siRNA (set 1- #1) knockdow...
Figure S1. Original blots of Western blot. Original blots of Fig. 1. (2) Original blots of Fig. 2. (...
Figure S7. Palbociclib treatment induces autophagy but not after a short treatment period. (A) MCL c...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S6. Palbociclib-mediated antagonism on bortezomib-induced cell death is not caused by alterat...
Figure S5. Inhibition CDK4 activity hardly alters NOXA mRNA levels after proteasome inhibition. MCL ...
Figure S4. CDK4 inhibition antagonizes cell death of NOXA inducing substances. MCL cell line Jeko-1 ...
Figure S2. Knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death. MCL cell line ...
Figure S11. Combination of proteasome inhibition and simultaneous fatty acid inhibition regulates ma...
Figure S3. Double knockdown of cyclin D1 and CDK4 antagonizes bortezomib-induced cell death similar ...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...
Table S1. Sequences targeted by the siRNAs used for gene silencing. (TIFF 883 kb
Figure S10. Synergistic cell death after proteasome inhibition and simultaneous fatty acid inhibitio...
Figure S12. Proteasome inhibitors combined with fatty acid inhibition induce synergistic cell death....
Figure S13. NOXA protein contains a potential LIR motif. The amino acid sequence DGFRRL at the posit...
Figure S1. Confirmation of silencing of BMX, NRTK2, and PDPK1 mediated by siRNA (set 1- #1) knockdow...
Figure S1. Original blots of Western blot. Original blots of Fig. 1. (2) Original blots of Fig. 2. (...